A carregar...
Value assessment in oncology drugs: funding of drugs for metastatic breast cancer in Canada
BACKGROUND: Life expectancy for women with metastatic breast cancer has improved since the early 2000s, in part because of the introduction of novel therapies, including chemotherapy, hormonal therapy, and targeted agents. However, those treatments can come at a cost for the patient (short- and long...
Na minha lista:
| Publicado no: | Curr Oncol |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Multimed Inc.
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6001763/ https://ncbi.nlm.nih.gov/pubmed/29910659 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3747/co.25.3846 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|